Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in Stiff Person Syndrome
NCT00091897Phase 2Completed
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- Sep 2004
- Primary completion
- Jul 2007
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in stiff person syndrome (SPS), sponsored by National Institute of Neurological Disorders and Stroke. Started Sep 2004; status: completed.
02
Drugs
rituximab
03
Conditions
stiff person syndrome (SPS)
Beyond the preview
Go deeper on NCT00091897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00091897.